STAAR Surgical Company (STAA)
| Previous close | 31.61 |
| Open | 31.68 |
| Bid | 31.70 x 900 |
| Ask | 31.75 x 800 |
| Day's range | 30.82 - 31.89 |
| 52-week range | 30.82 - 81.81 |
| Volume | |
| Avg. volume | 796,123 |
| Market cap | 1.545B |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | 83.29 |
| EPS (TTM) | 0.38 |
| Earnings date | 19 Feb 2024 - 23 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 47.75 |
Simply Wall St.Should Weakness in STAAR Surgical Company's (NASDAQ:STAA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
With its stock down 18% over the past month, it is easy to disregard STAAR Surgical (NASDAQ:STAA). However, the...
Business WireSTAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)
LAKE FOREST, Calif., November 15, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced that management will participate in the Stephens Annual Investment Conference on Thursday, November 16, 2023.
Insider MonkeySTAAR Surgical Company (NASDAQ:STAA) Q3 2023 Earnings Call Transcript
STAAR Surgical Company (NASDAQ:STAA) Q3 2023 Earnings Call Transcript November 1, 2023 STAAR Surgical Company beats earnings expectations. Reported EPS is $0.3, expectations were $0.2. Operator: Good day ladies and gentlemen. Thank you for standing by. Welcome to the STAAR Surgical Third Quarter Financial Results Conference Call. During today’s presentation, all parties will be in […]
